Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (78)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Shull, J. D.
Right arrow Articles by Pennington, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shull, J. D.
Right arrow Articles by Pennington, K. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 18, 1595-1601, Copyright © 1997 by Oxford University Press

ARTICLES

Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma

JD Shull, TJ Spady, MC Snyder, SL Johansson and KL Pennington
Eppley Institute for Research in Cancer and Allied Diseases, Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha 68198-6805, USA.

We have examined the ability of 17beta-estradiol (E2) to induce development of mammary cancers in the female ACI rat. Continuous treatment with E2, delivered through release from s.c. Silastic tubing implants containing 27.5 mg crystalline hormone, resulted in rapid development of palpable mammary tumors in ovary-intact ACI rats. In a population of 21 E2-treated rats, palpable tumors were first observed following 99 days treatment and 100% of the treated population developed tumors within 197 days. The median and mean times to appearance of first palpable tumor were 143 and 145 days respectively. All mammary tumors were classified as carcinomas and invasive features were observed. Circulating E2 levels in the treated animals at the time of sacrifice averaged 185 pg/ml serum. Mammary tumors were not observed in ovary-intact female ACI rats that were not treated with E2. This is the first report indicating that this naturally occurring estrogen is capable of inducing mammary cancers in the ACI rat strain. Mammary carcinoma did not develop in a population of 11 ovariectomized female ACI rats treated with E2 for a period of 140 days. Circulating E2 levels in the treated ovariectomized animals averaged 207 pg/ml. These data indicate that the ovary modulates estrogen-mediated mammary carcinogenesis in this rat strain. Both ovary-intact and ovariectomized female ACI rats displayed similar susceptibilities to E2-induced pituitary tumors and hyperprolactinemia. Pituitary weight was increased 6.0-fold in ovary-intact ACI rats and 5.3-fold in ovariectomized female rats. Circulating prolactin levels averaged 2318 ng/ml in E2-treated, ovary-intact rats and 2285 ng/ml in E2-treated, ovariectomized ACI rats. These data indicate that estrogen-induced hyperprolactinemia is not the sole factor leading to development of mammary cancers in the E2- treated ACI rat.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
A. G. Cleveland, S. I. Oikarinen, K. K. Bynote, M. Marttinen, J. J. Rafter, J.-A. Gustafsson, S. K. Roy, H. C. Pitot, K. S. Korach, D. B. Lubahn, et al.
Disruption of estrogen receptor signaling enhances intestinal neoplasia in ApcMin/+ mice
Carcinogenesis, September 1, 2009; 30(9): 1581 - 1590.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. M. Mense, B. Singh, F. Remotti, X. Liu, and H. K. Bhat
Vitamin C and {alpha}-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats
Carcinogenesis, July 1, 2009; 30(7): 1202 - 1208.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
E. X. Albuquerque, E. F. R. Pereira, M. Alkondon, and S. W. Rogers
Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function
Physiol Rev, January 1, 2009; 89(1): 73 - 120.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. G. Kurz, K. K. Hansen, M. T. McLaughlin, V. Shivaswamy, B. S. Schaffer, K. A. Gould, R. D. McComb, J. L. Meza, and J. D. Shull
Tissue-Specific Actions of the Ept1, Ept2, Ept6, and Ept9 Genetic Determinants of Responsiveness to Estrogens in the Female Rat
Endocrinology, August 1, 2008; 149(8): 3850 - 3859.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. W. Blank, P.-Y. Wong, R. Lakshmanaswamy, R. Guzman, and S. Nandi
Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats
PNAS, March 4, 2008; 105(9): 3527 - 3532.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
M. Alkondon, E. F. R. Pereira, M. C. Potter, F. C. Kauffman, R. Schwarcz, and E. X. Albuquerque
Strain-Specific Nicotinic Modulation of Glutamatergic Transmission in the CA1 Field of the Rat Hippocampus: August Copenhagen Irish Versus Sprague-Dawley
J Neurophysiol, February 1, 2007; 97(2): 1163 - 1170.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. S. Schaffer, C. M. Lachel, K. L. Pennington, C. R. Murrin, T. E. Strecker, M. Tochacek, K. A. Gould, J. L. Meza, R. D. McComb, and J. D. Shull
Genetic Bases of Estrogen-Induced Tumorigenesis in the Rat: Mapping of Loci Controlling Susceptibility to Mammary Cancer in a Brown Norway x ACI Intercross.
Cancer Res., August 1, 2006; 66(15): 7793 - 7800.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Mesia-Vela, R. I. Sanchez, K. R. Reuhl, A. H. Conney, and F. C. Kauffman
Phenobarbital Treatment Inhibits the Formation of Estradiol-Dependent Mammary Tumors in the August-Copenhagen Irish Rat
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 590 - 597.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. D. Yager and N. E. Davidson
Estrogen Carcinogenesis in Breast Cancer
N. Engl. J. Med., January 19, 2006; 354(3): 270 - 282.
[Full Text] [PDF]

Home page
 GeneticsHome page
T. E. Strecker, T. J. Spady, B. S. Schaffer, K. A. Gould, A. E. Kaufman, F. Shen, M. T. McLaughlin, K. L. Pennington, J. L. Meza, and J. D. Shull
Genetic Bases of Estrogen-Induced Pituitary Tumorigenesis: Identification of Genetic Loci Determining Estrogen-Induced Pituitary Growth in Reciprocal Crosses Between the ACI and Copenhagen Rat Strains
Genetics, April 1, 2005; 169(4): 2189 - 2197.
[Abstract] [Full Text] [PDF]

Home page
 GeneticsHome page
K. A. Gould, M. Tochacek, B. S. Schaffer, T. M. Reindl, C. R. Murrin, C. M. Lachel, E. A. VanderWoude, K. L. Pennington, L. A. Flood, K. K. Bynote, et al.
Genetic Determination of Susceptibility to Estrogen-Induced Mammary Cancer in the ACI Rat: Mapping of Emca1 and Emca2 to Chromosomes 5 and 18
Genetics, December 1, 2004; 168(4): 2113 - 2125.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
V K Turan, R I Sanchez, J J Li, S A Li, K R Reuhl, P E Thomas, A H Conney, M A Gallo, F C Kauffman, and S Mesia-Vela
The effects of steroidal estrogens in ACI rat mammary carcinogenesis: 17{beta}-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16{alpha}-hydroxyestradiol, and 4-hydroxyestrone
J. Endocrinol., October 1, 2004; 183(1): 91 - 99.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Oomizu, K. Chaturvedi, and D. K. Sarkar
Folliculostellate Cells Determine the Susceptibility of Lactotropes to Estradiol's Mitogenic Action
Endocrinology, March 1, 2004; 145(3): 1473 - 1480.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. S. Hamilton and T. M. Mack
Puberty and Genetic Susceptibility to Breast Cancer in a Case-Control Study in Twins
N. Engl. J. Med., June 5, 2003; 348(23): 2313 - 2322.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. K. Bhat, G. Calaf, T. K. Hei, T. Loya, and J. V. Vadgama
Critical role of oxidative stress in estrogen-induced carcinogenesis
PNAS, April 1, 2003; 100(7): 3913 - 3918.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. T. Hentges and M. J. Low
Ovarian Dependence for Pituitary Tumorigenesis in D2 Dopamine Receptor-Deficient Mice
Endocrinology, December 1, 2002; 143(12): 4536 - 4543.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Mesia-Vela, R. I. Sanchez, J. J. Li, S. A. Li, A. H. Conney, and F. C. Kauffman
Catechol estrogen formation in liver microsomes from female ACI and Sprague-Dawley rats: comparison of 2- and 4-hydroxylation revisited
Carcinogenesis, August 1, 2002; 23(8): 1369 - 1372.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. M.E Harvell, T. E. Strecker, B. Xie, K. L. Pennington, R. D. McComb, and J. D. Shull
Dietary energy restriction inhibits estrogen-induced mammary, but not pituitary, tumorigenesis in the ACI rat
Carcinogenesis, January 1, 2002; 23(1): 161 - 169.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. D. Shull, K. L. Pennington, T. M. Reindl, M. C. Snyder, T. E. Strecker, T. J. Spady, M. Tochacek, and R. D. McComb
Susceptibility to Estrogen-Induced Mammary Cancer Segregates as an Incompletely Dominant Phenotype in Reciprocal Crosses between the ACI and Copenhagen Rat Strains
Endocrinology, December 1, 2001; 142(12): 5124 - 5130.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
D. M. E. Harvell, T. E. Strecker, B. Xie, L. K. Buckles, M. Tochacek, R. D. McComb, and J. D. Shull
Diet-Gene Interactions in Estrogen-Induced Mammary Carcinogenesis in the ACI Rat
J. Nutr., November 1, 2001; 131(11): 3087S - 3091.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. M. Wilson and G. A. Reed
Predominant 4-hydroxylation of estradiol by constitutive cytochrome P450s in the female ACI rat liver
Carcinogenesis, February 1, 2001; 22(2): 257 - 263.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
J. Ashby
Validation of In Vitro and In Vivo Methods for Assessing Endocrine Disrupting Chemicals
Toxicol Pathol, May 1, 2000; 28(3): 432 - 437.
[Abstract] [PDF]

Home page
 Endocr. Rev.Home page
J. G. Liehr
Is Estradiol a Genotoxic Mutagenic Carcinogen?
Endocr. Rev., February 1, 2000; 21(1): 40 - 54.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
T. J. Spady, K. L. Pennington, R. D. McComb, and J. D. Shull
Genetic Bases of Estrogen-Induced Pituitary Growth in an Intercross between the ACI and Copenhagen Rat Strains: Dominant Mendelian Inheritance of the ACI Phenotype
Endocrinology, June 1, 1999; 140(6): 2828 - 2835.
[Abstract] [Full Text]

Home page
 J. Nutr.Home page
T. J. Spady, D. M. E. Harvell, A. Lemus-Wilson, T. E. Strecker, K. L. Pennington, E. A. Vander Woude, D. F. Birt, R. D. McComb, and J. D. Shull
Modulation of Estrogen Action in the Rat Pituitary and Mammary Glands by Dietary Energy Consumption
J. Nutr., February 1, 1999; 129(2): 587 - 587.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. M. E. Harvell, T. E. Strecker, M. Tochacek, B. Xie, K. L. Pennington, R. D. McComb, S. K. Roy, and J. D. Shull
Rat strain-specific actions of 17beta -estradiol in the mammary gland: Correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers
PNAS, March 14, 2000; 97(6): 2779 - 2784.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.